Zobrazeno 1 - 10
of 2 548
pro vyhledávání: '"HODGSON, DR"'
Autor:
Barnicle A; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA, UK. alan.barnicle@astrazeneca.com., Ray-Coquard I; Medical Oncology Department, Centre Léon Bérard and University Claude Bernard Lyon, and Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO), Lyon, France., Rouleau E; Department of Medical Biology and Pathology, Gustave Roussy, Cancer Genetics Laboratory, Gustave Roussy, Villejuif, France., Cadoo K; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Simpkins F; Department of Obstetrics and Gynecology, Jordan Center for Gynecologic Oncology at the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Aghajanian C; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Leary A; Institut Gustave Roussy, and GINECO, Villejuif, France., Poveda A; Initia Oncology, Hospital Quironsalud, Valencia, Spain., Lheureux S; Department of Medical Oncology, Princess Margaret Hospital, Toronto, ONT, Canada., Pujade-Lauraine E; Association de Recherche Cancers Gynécologiques (ARCAGY)-GINECO, and GINECO, Paris, France., You B; Medical Oncology, IC-HCL, EPSILYON, Univ Lyon 1, and GINECO, Lyon, France., Ledermann J; UCL Cancer Institute, University College London and UCL Hospitals, London, UK., Matulonis U; Dana-Farber Cancer Institute, Boston, MA, USA., Gourley C; Cancer Research UK Scotland Centre, University of Edinburgh, Edinburgh, UK., Timms KM; Myriad Genetics, Salt Lake City, UT, USA., Lai Z; Translational Medicine, Oncology R&D, Research and Early Development, AstraZeneca, Boston, MA, USA., Hodgson DR; Translational Medicine, Oncology R&D, Research and Early Development, AstraZeneca, Boston, MA, USA., Elks CE; Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Cambridge, UK., Dearden S; Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Cambridge, UK., Egile C; Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Cambridge, UK., Lao-Sirieix P; Precision Medicine and Biosamples, Oncology R&D, AstraZeneca, Cambridge, UK., Harrington EA; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA, UK., Brown JS; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, CB2 0AA, UK.
Publikováno v:
Genome medicine [Genome Med] 2024 Dec 18; Vol. 16 (1), pp. 145. Date of Electronic Publication: 2024 Dec 18.
Publikováno v:
The North American Review, 1867 Oct 01. 105(217), 629-634.
Externí odkaz:
https://www.jstor.org/stable/25108109
Autor:
Lenz L; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Neff C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Solimeno C; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Cogan ES; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Abramson VG; Vanderbilt University Medical Center, Nashville, TN, USA., Boughey JC; Mayo Clinic, Rochester, MN, USA., Falkson C; University of Rochester Medical Center, Rochester, NY, USA., Goetz MP; Mayo Clinic, Rochester, MN, USA., Ford JM; Stanford University School of Medicine, Stanford, CA, USA., Gradishar WJ; Northwestern University, Chicago, IL, USA., Jankowitz RC; University of Pennsylvania, Philadelphia, PA, USA., Kaklamani VG; University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Marcom PK; Duke University, Durham, NC, USA., Richardson AL; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Storniolo AM; Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA., Tung NM; Beth Israel Deaconess Medical Center, Boston, MA, USA., Vinayak S; University of Washington, Seattle, WA, USA.; Fred Hutchinson Cancer Research Center, 15. AstraZeneca, Seattle, WA, USA., Hodgson DR; AstraZeneca, Cambridge, UK., Lai Z; AstraZeneca, Boston, MA, USA., Dearden S; AstraZeneca, Cambridge, UK., Hennessy BT; Royal College of Surgeons in Ireland, Dublin, Ireland., Mayer EL; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Mills GB; Oregon Health & Science University, Portland, OR, USA., Slavin TP; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Gutin A; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Connolly RM; Cancer Research @UCC, University College Cork, Cork, Ireland., Telli ML; Stanford University School of Medicine, Stanford, CA, USA., Stearns V; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA., Lanchbury JS; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA., Timms KM; Myriad Genetics, Inc, 320 Wakara Way, Salt Lake City, UT, 84108, USA. ktimms@myriad.com.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Nov; Vol. 202 (1), pp. 191-201. Date of Electronic Publication: 2023 Aug 17.
Autor:
Hodgson, Dr Kate
It suited European colonial powers to benefit economically from slavery while keeping it largely at arm’s length. Colonial policing and plantation management were outsourced where possible, and many colonists aspired to make a fortune and return to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=openedition_::423ba6204a68b69ef0d211293402befc
http://journals.openedition.org/slaveries/4814
http://journals.openedition.org/slaveries/4814
Autor:
Vervuert, Ingrid1 ingrid.vervuert@vetmed.uni-leipzig.de
Publikováno v:
Pferdeheilkunde. Jul/Aug2024, Vol. 40 Issue 4, p345-349. 5p.
Autor:
Hodgson DR; Translational Medicine, Oncology R+D, Research and Early Development, AstraZeneca, Boston, MA, USA., Brown JS; Translational Medicine, Oncology R+D, Research and Early Development, AstraZeneca, Cambridge, United Kingdom. Electronic address: jessica.brown1@astrazeneca.com., Dearden SP; Precision Medicine and Biosamples, R&D Oncology, AstraZeneca, Cambridge, United Kingdom., Lai Z; Translational Medicine, Oncology R+D, Research and Early Development, AstraZeneca, Boston, MA, USA., Elks CE; Precision Medicine and Biosamples, R&D Oncology, AstraZeneca, Cambridge, United Kingdom., Milenkova T; AstraZeneca, Cambridge, United Kingdom., Dougherty BA; Translational Medicine, Oncology R+D, Research and Early Development, AstraZeneca, Boston, MA, USA., Lanchbury JS; Myriad Genetics, Salt Lake City, UT, USA., Perry M; Myriad Genetics, Salt Lake City, UT, USA., Timms KM; Myriad Genetics, Salt Lake City, UT, USA., Harrington EA; Translational Medicine, Oncology R+D, Research and Early Development, AstraZeneca, Cambridge, United Kingdom., Barrett JC; Translational Medicine, Oncology R+D, Research and Early Development, AstraZeneca, Boston, MA, USA., Leary A; Department of Medicine and INSERM U981, Université Paris Saclay and Institut Gustave-Roussy, Villejuif, France., Pujade-Lauraine E; Medical Oncology Department, Université Paris Descartes, AP-HP, Paris, France.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2021 Dec; Vol. 163 (3), pp. 563-568. Date of Electronic Publication: 2021 Nov 04.
Autor:
Bogossian, Paulo M.1,2 (AUTHOR), Nattala, Usha3 (AUTHOR), Wong, Adelene S. M.2 (AUTHOR), Morrice-West, Ashleigh V.2 (AUTHOR), Zhang, Geordie Z.3 (AUTHOR), Rana, Pratibha3 (AUTHOR), Whitton, R. Chris2 (AUTHOR), Hitchens, Peta L.2 (AUTHOR) peta.hitchens@unimelb.edu.au
Publikováno v:
Scientific Reports. 11/22/2024, Vol. 14 Issue 1, p1-13. 13p.
Autor:
Gomez, Diego E.1 (AUTHOR), Kopper, Jamie J.2 (AUTHOR), Byrne, David P.3 (AUTHOR), Renaud, David L.4 (AUTHOR), Schoster, Angelika5,6 (AUTHOR), Dunkel, Bettina7 (AUTHOR), Arroyo, Luis G.1 (AUTHOR), Mykkanen, Anna8 (AUTHOR), Gilsenan, William F.9 (AUTHOR), Pihl, Tina H.10 (AUTHOR), Lopez-Navarro, Gabriela11 (AUTHOR), Tennent-Brown, Brett S.12 (AUTHOR), Hostnik, Laura D.13 (AUTHOR), Mora-Pereira, Mariano14 (AUTHOR), Marques, Fernando15 (AUTHOR), Gold, Jenifer R.16,17 (AUTHOR), DeNotta, Sally L.18 (AUTHOR), Desjardins, Isabelle19 (AUTHOR), Stewart, Allison J.20 (AUTHOR), Kuroda, Taisuke21 (AUTHOR)
Publikováno v:
PLoS ONE. 11/20/2024, Vol. 19 Issue 11, p1-19. 19p.
Autor:
Judge, Ciara1,2,3 (AUTHOR) ciara.judge@lshtm.ac.uk, Vaughan, Timothy4,5 (AUTHOR), Russell, Timothy1,2 (AUTHOR), Abbott, Sam1,2 (AUTHOR), du Plessis, Louis4,5 (AUTHOR), Stadler, Tanja4,5 (AUTHOR), Brady, Oliver1,2 (AUTHOR) oliver.brady@lshtm.ac.uk, Hill, Sarah3 (AUTHOR) sahill@rvc.ac.uk
Publikováno v:
PLoS Computational Biology. 11/11/2024, Vol. 20 Issue 11, p1-28. 28p.
Autor:
Trager LR; Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, USA., Funk RA; Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, USA., Clapp KS; Department of Small Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, USA., Dahlgren LA; Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, USA., Werre SR; Laboratory for Study Design and Statistical Analysis, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, USA., Hodgson DR; Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, USA., Pleasant RS; Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia, USA.
Publikováno v:
Equine veterinary journal [Equine Vet J] 2020 Mar; Vol. 52 (2), pp. 250-257. Date of Electronic Publication: 2019 Sep 04.